ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,332,925 | -77.4% | 1,103,576 | -70.8% | 0.06% | -80.6% |
| Q3 2022 | $72,337,000 | +70.8% | 3,785,277 | +90.5% | 0.29% | +61.5% |
| Q2 2022 | $42,352,000 | +29.5% | 1,987,431 | +17.1% | 0.18% | +37.7% |
| Q1 2022 | $32,701,000 | -40.4% | 1,697,849 | -35.8% | 0.13% | -40.6% |
| Q4 2021 | $54,840,000 | +15.2% | 2,644,177 | +32.7% | 0.22% | +4.8% |
| Q3 2021 | $47,591,000 | +94.5% | 1,992,107 | +122.2% | 0.21% | +90.0% |
| Q2 2021 | $24,463,000 | +92.5% | 896,400 | +104.1% | 0.11% | +86.4% |
| Q1 2021 | $12,709,000 | -48.4% | 439,300 | -49.8% | 0.06% | -50.8% |
| Q4 2020 | $24,619,000 | +1843.1% | 875,200 | +1923.3% | 0.12% | +1900.0% |
| Q3 2020 | $1,267,000 | – | 43,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $314,175,000 | 35.62% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $118,583,000 | 20.06% |
| Omega Fund Management, LLC | 844,680 | $25,171,000 | 10.42% |
| Vivo Capital, LLC | 1,686,527 | $50,259,000 | 4.55% |
| Orbimed Advisors | 4,673,850 | $139,281,000 | 2.34% |
| RA Capital Management | 1,165,184 | $34,722,000 | 1.10% |
| Polar Capital LLP | 375,000 | $11,175,000 | 0.12% |
| CAAS CAPITAL MANAGEMENT LP | 22,413 | $668,000 | 0.07% |
| FMR LLC | 5,713,343 | $170,258,000 | 0.02% |
| Laurion Capital Management LP | 50,000 | $1,490,000 | 0.02% |